REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform...
5 insider purchases on record · latest filing 2026-08-27.
Insiders have also filed 437 sale transactions at RGNX.